The BMP type II receptor is located in lipid rafts, including caveolae, of pulmonary endothelium in vivo and in vitro

被引:41
作者
Ramos, M
Lamé, MW
Segall, HJ
Wilson, DW
机构
[1] Univ Calif Davis, Dept Vet Med Pathol Immunol Microbiol, Davis, CA 95616 USA
[2] Univ Calif Davis, Dept Vet Med Mol Biosci, Davis, CA 95616 USA
关键词
bone morphogenetic protein type II receptor; caveolae; pulmonary hypertension;
D O I
10.1016/j.vph.2005.09.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Polymorphic mutations in the Bone Morphogenetic Protein type II receptor (BMPrII) gene have been implicated in the development of familial primary pulmonary hypertension (PPH) however, the role BMPrII mutations play in the development of PH has not yet been elucidated. Endothelial caveolae are an important domain of hemodynamics containing eNOS, the serotonin transporter, and endothelin receptors. In this study we show by standard immunohistochemistry (IHC) that BMPrII is widely distributed in the vasculature of the rat lung, and more specifically distributed to both apical and basal membranes of the arteriolar endothelium by fluorescent IHC. We also examined compartmentalization of BMPrII in lipid fractions of plasma membranes isolated by silica based extraction from human pulmonary artery endothelial cells and rat lung endothelium. Density gradient centrifugation demonstrated BMPrII in separate caveolin-1 (cav-1) and non-cav-1 lipid rich fractions. Electron microscopy co-localized cav-1 and BMPrII in flask shaped membrane fragments. Three-dimensional fluorescence microscopy demonstrated BMPrII in discrete membrane foci, a portion of which were co-localized with cav-1, as well as in Golgi. Our findings indicate that BMPrII is located within lipid-dense fractions of pulmonary endothelial cell membranes with a portion present in caveolae suggesting potential dynamic regulatory structural relationships. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:50 / 59
页数:10
相关论文
共 55 条
[1]   Isolation of a caveolae-enriched fraction from rat lung by affinity partitioning and sucrose gradient centrifugation [J].
Abedinpour, P ;
Jergil, B .
ANALYTICAL BIOCHEMISTRY, 2003, 313 (01) :1-8
[2]   Expression of bone morphogenetic protein-6 and bone morphogenetic protein receptors in myoepithelial cells of canine mammary gland tumors [J].
Akiyoshi, T ;
Uchida, K ;
Tateyama, S .
VETERINARY PATHOLOGY, 2004, 41 (02) :154-163
[3]   Cell biology - A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains [J].
Anderson, RGW ;
Jacobson, K .
SCIENCE, 2002, 296 (5574) :1821-1825
[4]   The caveolae membrane system [J].
Anderson, RGW .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :199-225
[5]   Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor [J].
Atkinson, C ;
Stewart, S ;
Upton, PD ;
Machado, R ;
Thomson, JR ;
Trembath, RC ;
Morrell, NW .
CIRCULATION, 2002, 105 (14) :1672-1678
[6]   cDNA cloning and genomic organization of the mouse BMP type II receptor [J].
Beppu, H ;
Minowa, O ;
Miyazono, K ;
Kawabata, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 235 (03) :499-504
[7]   In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation [J].
Bucci, M ;
Gratton, JP ;
Rudic, RD ;
Acevedo, L ;
Roviezzo, F ;
Cirino, G ;
Sessa, WC .
NATURE MEDICINE, 2000, 6 (12) :1362-1367
[8]  
CHANEY LK, 1983, J BIOL CHEM, V258, P62
[9]   Localization of phospholipase D in detergent-insoluble, caveolin-rich membrane domains -: Modulation by caveolin-1 expression and caveolin-182-101 [J].
Czarny, M ;
Lavie, Y ;
Fiucci, G ;
Liscovitch, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (05) :2717-2724
[10]   The transforming growth factor-β superfamily of receptors [J].
de Caestecker, M .
CYTOKINE & GROWTH FACTOR REVIEWS, 2004, 15 (01) :1-11